Ms Small — appearing in the place of Pfizer chief executive Albert Bourla, who had been called to testify but pulled out of the hearing earlier this month — replied that the company had to “move at the speed of science”.
“Regarding the question around, um, did we know about stopping the immunisation [sic] before it entered the market? No, heh,” she said.
“Uh, these, um, you know, we had to really move at the speed of science to really understand what is taking place in the market, and from that point of view we had to do everything at risk. I think Dr Bourla, even though he’s not here, would turn around and say to you himself, ‘If not us then who?’”
Ms Small said Dr Bourla “actually felt the importance of what was going on in the world, and therefore as a result of that, we actually, um, spent $US2 billion, at risk, of self-funded money from Pfizer, to be able to research, develop and manufacture at risk, to be able to make sure that we were in a position to be able to help with the pandemic”.
Continued:
In the early stages of the global rollout, drugmakers and public health authorities claimed the shots would prevent transmission of the virus, with Dr Bourla stating in April 2021 that early trial data showed its vaccine was “100 per cent effective against severe Covid-19”.
Initially a small number of so-called “breakthrough” infections were reported, but by late 2021 it had become clear the vaccinated were still catching and spreading the virus.
Health officials in countries including Australia now say that although the vaccines do not completely prevent transmission, they reduce the severity of the disease and so ease the strain on hospitals.
Earlier this year, White House chief medical adviser Dr Anthony Fauci admitted the Covid vaccines “don’t protect overly well against infection, they protect quite well against severe disease leading to hospitalisation and death”.
In January, Dr Bourla said two doses of the vaccine offered “very limited protection, if any” against the Omicron variant.
Pfizer made nearly $US37 billion in sales from its Covid vaccine last year — making it one of the most lucrative products in history, The Guardian noted — with overall revenue doubling in 2021 to $US81.3 billion.
*****************************************************************
The Pet Rock was marginally more successful...
Actually if they had just passed out pet rocks instead of forcing everyone to get a worthless and dangerous vaccine, the results would have been no different.
The vaccines don’t stop you from getting the virus or spreading it. Neither does a pet rock, but a pet rock won’t kill you.